# Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms

> **NCT01457573** · PHASE4 · COMPLETED · sponsor: **Timothy Boone, MD, PhD** · enrollment: 10 (actual)

## Conditions studied

- Lower Urinary Tract Symptoms

## Interventions

- **DRUG:** Tamsulosin
- **DRUG:** Solifenacin

## Key facts

- **NCT ID:** NCT01457573
- **Lead sponsor:** Timothy Boone, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01457573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01457573, "Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01457573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*